🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Chuck Royce’s CDNA Holdings & Trades

First Buy
Q4 2014
Duration Held
45 Quarters
Largest Add
Q2 2023
+358,100 Shares
Current Position
581,211 Shares
$10.95 M Value

Chuck Royce's CDNA Position Overview

Chuck Royce (via Royce & Associates Lp) currently holds 581,211 shares of CareDx, Inc. (CDNA) worth $10.95 M, representing 0.11% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 45 quarters.

Based on 13F filings since 2013, Chuck Royce has maintained a long-term strategic position in CDNA, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2023, adding 358,100 shares. Largest reduction occurred in Q4 2023, reducing 717,850 shares.

Analysis based on 13F filings available since 2013 Q2

Chuck Royce's CareDx (CDNA) Holding Value Over Time

Track share changes against reported price movement

Quarterly CareDx (CDNA) Trades by Chuck Royce

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +176,817 Add 43.72% 581,211 $18.84
Q3 2025 -374,210 Reduce 48.06% 404,394 $14.54
Q2 2025 +295,273 Add 61.09% 778,604 $19.54
Q1 2025 -955 Reduce 0.20% 483,331 $17.75
Q4 2024 +91,000 Add 23.14% 484,286 $21.41
Q3 2024 +1,000 Add 0.25% 393,286 $31.22
Q2 2024 -146,012 Reduce 27.12% 392,286 $15.53
Q1 2024 +194,593 Add 56.62% 538,298 $10.59
Q4 2023 -717,850 Reduce 67.62% 343,705 $12.00
Q3 2023 +270,950 Add 34.27% 1.06 M $7.00
Q2 2023 +358,100 Add 82.80% 790,605 $8.50
Q1 2023 +332,400 Add 332.05% 432,505 $9.14
Q4 2022 -67,000 Reduce 40.09% 100,105 $11.41
Q3 2022 -48,650 Reduce 22.55% 167,105 $17.02
Q2 2022 -66,300 Reduce 23.51% 215,755 $21.48
Q1 2022 +5,000 Add 1.80% 282,055 $36.99
Q4 2021 +52,535 Add 23.40% 277,055 $45.48
Q3 2021 -92,600 Reduce 29.20% 224,520 $63.37
Q2 2021 +37,500 Add 13.41% 317,120 $91.52
Q1 2021 -175,779 Reduce 38.60% 279,620 $68.09
Q4 2020 -11,079 Reduce 2.38% 455,399 $72.45
Q3 2020 -87,900 Reduce 15.86% 466,478 $37.94
Q2 2020 -25,482 Reduce 4.39% 554,378 $35.43
Q1 2020 +35,298 Add 6.48% 579,860 $21.83
Q4 2019 +217,138 Add 66.32% 544,562 $21.57
Q3 2019 +187,112 Add 133.35% 327,424 $22.61
Q2 2019 -99,800 Reduce 41.56% 140,312 $35.99
Q1 2019 -135,400 Reduce 36.06% 240,112 $31.52
Q4 2018 -193,610 Reduce 34.02% 375,512 $25.14
Q3 2018 -297,261 Reduce 34.31% 569,122 $28.85
Q2 2018 -137,204 Reduce 13.67% 866,383 $12.24
Q1 2018 +30,500 Add 3.13% 1 M $7.97
Q4 2017 +180,300 Add 22.74% 973,087 $7.34
Q3 2017 +59,500 Add 8.11% 792,787 $3.70
Q2 2017 +206,815 Add 39.28% 733,287 $1.11
Q1 2017 +100,111 Add 23.48% 526,472 $1.40
Q4 2016 +178,743 Add 72.18% 426,361 $2.70
Q3 2016 +112,873 Add 83.77% 247,618 $3.55
Q2 2016 +48,828 Add 56.83% 134,745 $4.32
Q1 2016 +11,503 Add 15.46% 85,917 $4.96
Q4 2015 +13,500 Add 22.16% 74,414 $6.40
Q3 2015 +29,865 Add 96.19% 60,914 $4.17
Q2 2015 +8,800 Add 39.55% 31,049 $6.51
Q1 2015 +10,800 Add 94.33% 22,249 $5.53
Q4 2014 +11,449 New Buy 11,449 $7.25

Chuck Royce's CareDx Investment FAQs

Chuck Royce first purchased CareDx, Inc. (CDNA) in Q4 2014, acquiring 11,449 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Chuck Royce has held CareDx, Inc. (CDNA) for 45 quarters since Q4 2014.

Chuck Royce's largest addition to CareDx, Inc. (CDNA) was in Q2 2023, adding 790,605 shares worth $6.72 M.

According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 581,211 shares of CareDx, Inc. (CDNA), valued at approximately $10.95 M.

As of the Q4 2025 filing, CareDx, Inc. (CDNA) represents approximately 0.11% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.

Chuck Royce's peak holding in CareDx, Inc. (CDNA) was 1,061,555 shares, as reported at the end of Q3 2023.